Recursion Pharmaceuticals, Inc. logo

RXRXRecursion Pharmaceuticals, Inc.

RXRX Stock Price, Valuation & Chart | Recursion Pharmaceuticals, Inc.

Compare

RXRX Historical price chart

RXRX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization1.77B
PE Ratio-3.25
EPS-1.04
Trading Volume14.01M
Today's High/Low3.48/3.29
Dividend Yield0.00
52 Week High/Low7.18/2.77
Shares Outstanding524.68M
RXRX Financial Statement
RXRX Analyst ratings
RXRX Analysis & performance metrics

RXRX Company profile

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology,…

RXRX Management team

Management
Ben R. TaylorCFO
Chief Financial Officer & President of Recursion UK
Kevin Leggat
Vice President of Finance & Accounting
David J. Mauro M.D., Ph.D.
Chief Medical Officer
Benjamin Mabey M.S.CTO
Chief Technology Officer
Christopher C. Gibson Ph.D.CEO
Co-Founder, Chief Executive Officer & Director
Najat Khan Ph.D.CTO
Chief R&D Officer, Chief Commercial Officer and Director
David Hallett Ph.D.
Chief Scientific Officer
Nathan Hatfield J.D., M.B.A.
Chief Legal Officer & General Counsel
Total 8 executives

RXRX Frequently asked questions

What is Recursion Pharmaceuticals, Inc. (RXRX) Stock Price?

Current stock price of Recursion Pharmaceuticals, Inc. (RXRX) stock is $3.380. The stock price is +1.50% higher in the session. The intraday range can be seen from this page. Volume of Recursion Pharmaceuticals, Inc. (RXRX) stock is 14.01M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Recursion Pharmaceuticals, Inc. (RXRX) stock price going up or down today?

The stock price of Recursion Pharmaceuticals, Inc. (RXRX) can change with earnings, company news, and overall market sentiment. Recursion Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Recursion Pharmaceuticals, Inc. stock expensive at its current price?

Whether Recursion Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RXRX on this page is -3.25. EPS on this page is -1.04. Compare those figures with peers and growth expectations before deciding if the current Recursion Pharmaceuticals, Inc. price is justified.

How has the stock price of Recursion Pharmaceuticals, Inc. (RXRX) performed historically?

Historical performance for Recursion Pharmaceuticals, Inc. (RXRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RXRX reacted to past earnings and market events.

Should I buy Recursion Pharmaceuticals, Inc. (RXRX) stock, at this price?

Buying Recursion Pharmaceuticals, Inc. (RXRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.